Evaluation of Root Coverage After the Use of Coronally Advanced Flap Either With Advanced Paltelet Rich Fibrin or Subepithilial Connective Tissue Graft in Treatment of Miller Class I and II Gingival Recession.
NCT ID: NCT03695549
Last Updated: 2018-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2018-10-31
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Null hypothesis: In patients with Miller class I and II gingival recession, there is no difference in amount of root coverage (mm) following the application of SCTG+A-PRF compared to CAF+SCTG.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession
NCT03199118
Soft Tissue Augmentation Using Deepithelialized Free Gingival Graft Compared to Connective Tissue Graft in Management of Miller Class I and II Gingival Recession.
NCT03213483
Effectiveness of the Papillary Extended Connective Tissue Graft in Miller Class III Gingival Recession
NCT03416673
Treatment of Miller Class I and II Gingival Recession Using Non- Pedicled Buccal Fat Pad Graft as Compared to Subepithelial Connective Tissue Graft
NCT03543163
Clinical Evaluation of Tunneled Coronally Advanced Flap v.s Coronally Advanced Flap With Graft for Gingival Recession
NCT06553677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Intervention (I): Coronally advanced flap (CAF) plus platelet rich fibrin (A-PRF).
* Comparator (C): Coronally advanced flap (CAF) plus subepithelial connective tissue graft (SCTG).
* Primary Outcome (O): Root coverage (mm).
* Time frame: 9 months.
* Study design: Randomized controlled clinical trial.
* Patients are to be selected from the outpatient clinic of the department of Oral Medicine and Periodontology-Cairo University
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
CAF+ APRF
CAF + (A-PRF)
advanced platelet rich fibrin prepared by low speed centrfugation concept(LSCC) together with coronally advanced flap .
control
CAF+SCTG
CAF+SCTG
cornally advanced flap plus subepithilial connective tissue graft harvested from the palate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAF + (A-PRF)
advanced platelet rich fibrin prepared by low speed centrfugation concept(LSCC) together with coronally advanced flap .
CAF+SCTG
cornally advanced flap plus subepithilial connective tissue graft harvested from the palate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good oral hygiene after phase I therapy.
* Miller's class I or II gingival recession.
* Not using antibiotics, steroids, chemotherapy or other medications that may modify results of the surgery and healing.
* Cooperative patients able and accept to come for follow up appointments
Exclusion Criteria
* Current Smokers.
* Patients with any systemic disease that may affect the periodontal healing.
* Teeth with endodontic treatment, buccal restoration or caries.
* Patients with poor oral hygiene
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
heba samir
assistant lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heba Samir Mhmoud, assistant lecturer
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Manal M Hosny, professor
Role: STUDY_DIRECTOR
Cairo University
Engi A Mahmoud, assistant professor
Role: STUDY_CHAIR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
assistant lecturer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.